Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial (vol 23, pg P183, 2023)

被引：0
|
作者：
Khoo, S. H.
FitzGerald, R.
Saunders, G.
机构：
来源：
LANCET INFECTIOUS DISEASES | 2023年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E1 / E1
页数：1
相关论文
共 50 条
  • [11] Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial
    Vaclavkova, Andrea
    Chimenti, Sergio
    Arenberger, Petr
    Hollo, Peter
    Sator, Paul-Gunther
    Burcklen, Michel
    Stefani, Mylene
    D'Ambrosio, Daniele
    LANCET, 2014, 384 (9959): : 2036 - 2045
  • [12] Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial (vol 392, pg 222, 2018)
    Wallace, D. J.
    Furie, R. A.
    Tanaka, Y.
    LANCET, 2018, 392 (10146): : 476 - 476
  • [13] Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial
    Haik, Stephane
    Marcon, Gabriella
    Mallet, Alain
    Tettamanti, Mauro
    Welaratne, Arlette
    Giaccone, Giorgio
    Azimi, Shohreh
    Pietrini, Vladimir
    Fabreguettes, Jean-Roch
    Imperiale, Daniele
    Cesaro, Pierre
    Buffa, Carlo
    Aucan, Christophe
    Lucca, Ugo
    Peckeu, Laurene
    Suardi, Silvia
    Tranchant, Christine
    Zerr, Ingo
    Houillier, Caroline
    Redaelli, Veronica
    Vespignani, Herve
    Campanella, Angela
    Sellal, Francois
    Krasnianski, Anna
    Seilhean, Danielle
    Heinemann, Uta
    Sedel, Frederic
    Canovi, Mara
    Gobbi, Marco
    Di Fede, Giuseppe
    Laplanche, Jean-Louis
    Pocchiari, Maurizio
    Salmona, Mario
    Forloni, Gianluigi
    Brandel, Jean-Philippe
    Tagliavini, Fabrizio
    LANCET NEUROLOGY, 2014, 13 (02): : 150 - 158
  • [14] Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial
    Miller, David H.
    Weber, Thomas
    Grove, Richard
    Wardell, Claire
    Horrigan, Joseph
    Graff, Ole
    Atkinson, Gillian
    Dua, Pinky
    Yousry, Tarek
    MacManus, David
    Montalban, Xavier
    LANCET NEUROLOGY, 2012, 11 (02): : 131 - 139
  • [15] Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
    Fellstroem, Bengt C.
    Barratt, Jonathan
    Cook, Heather
    Coppo, Rosanna
    Feehally, John
    de Fijter, Johan W.
    Floege, Juergen
    Hetzel, Gerd
    Jardine, Alan G.
    Locatelli, Francesco
    Maes, Bart D.
    Mercer, Alex
    Ortiz, Fernanda
    Praga, Manuel
    Sorensen, Soren S.
    Tesar, Vladimir
    Del Vecchio, Lucia
    LANCET, 2017, 389 (10084): : 2117 - 2127
  • [16] Immunogenicity and Safety of a 3-Dose Regimen of a SARS-CoV-2 Inactivated Vaccine in Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
    Liu, Jiankai
    Huang, Baoying
    Li, Guifan
    Chang, Xianyun
    Liu, Yafei
    Chu, Kai
    Hu, Jialei
    Deng, Yao
    Zhu, Dandan
    Wu, Jingliang
    Zhang, Li
    Wang, Meng
    Huang, Weijin
    Pan, Hongxing
    Tan, Wenjie
    JOURNAL OF INFECTIOUS DISEASES, 2022, 225 (10): : 1701 - 1709
  • [17] Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
    Zhu, Fengcai
    Huang, Shoujie
    Liu, Xiaohui
    Chen, Qi
    Zhuang, Chunlan
    Zhao, Hui
    Han, Jinle
    Jaen, Anjuli May
    Do, Thai Hung
    Peter, Jonathan Grant
    Dorado, Alexander Gonzalez
    Tirador, Louie S.
    Zabat, Gelza Mae A.
    Villalobos, Ralph Elvi M.
    Gueco, Gemalyn Pineda
    Botha, Lauren Livia Greta
    Pertuz, Shirley Patricia Iglesias
    Tan, Jiaxiang
    Zhu, Kongxin
    Quan, Jiali
    Lin, Hongyan
    Huang, Yue
    Jia, Jizong
    Chu, Xiafei
    Chen, Junyu
    Chen, Yixin
    Zhang, Tianying
    Su, Yingying
    Li, Changgui
    Ye, Xiangzhong
    Wu, Ting
    Zhang, Jun
    Xia, Ningshao
    LANCET RESPIRATORY MEDICINE, 2023, 11 (12): : 1075 - 1088
  • [18] Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial
    Raghu, Ganesh
    Brown, Kevin K.
    Collard, Harold R.
    Cottin, Vincent
    Gibson, Kevin F.
    Kaner, Robert J.
    Lederer, David J.
    Martinez, Fernando J.
    Noble, Paul W.
    Song, Jin Woo
    Wells, Athol U.
    Whelan, Timothy P. M.
    Wuyts, Wim
    Moreau, Emmanuel
    Patterson, Scott D.
    Smith, Victoria
    Bayly, Selina
    Chien, Jason W.
    Gong, Qi
    Zhang, Jenny J.
    O'Riordan, Thomas G.
    LANCET RESPIRATORY MEDICINE, 2017, 5 (01): : 22 - 32
  • [19] Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial
    Wills, Anne-Marie
    Hubbard, Jane
    Macklin, Eric A.
    Glass, Jonathan
    Tandan, Rup
    Simpson, Ericka P.
    Brooks, Benjamin
    Gelinas, Deborah
    Mitsumoto, Hiroshi
    Mozaffar, Tahseen
    Hanes, Gregory P.
    Ladha, Shafeeq S.
    Heiman-Patterson, Terry
    Katz, Jonathan
    Lou, Jau-Shin
    Mahoney, Katy
    Grasso, Daniela
    Lawson, Robert
    Yu, Hong
    Cudkowicz, Merit
    LANCET, 2014, 383 (9934): : 2065 - 2072
  • [20] A phase 2, double-blind, placebo-controlled trial of a valproate/lithium combination in ALS patients
    Boll, M. -c.
    Alcaraz-Zubeldia, M.
    Rios, C.
    Gonzalez-Esquivel, D.
    Montes, S.
    NEUROLOGIA, 2025, 40 (01): : 32 - 40
12345